Cross-continental phylogenetic analysis is important to understand subtle molecular differences of currently circulating hepatitis C virus (HCV) subtypes. Existence of such differences can be crucial in pursuing a universal hepatitis C vaccine. We characterized . One hundred and ninety-two full-length HCV genomes were amplified from plasma of incident infections and subjected to next generation sequencing to establish the largest cross-continental, fulllength acute HCV genomic data set available to date. Genomes from the most common subtypes (1a: n=94, 2b: n=15 and 3a: n=68) were used in phylogenetic analysis. Using full genome trees, 78 sequences (44%) were found to lie within 29 phylogenetic clusters/pairs defined on the basis of molecular similarity of consensus sequences. Of these, 26 each had exclusively Australian or North American sequences indicating a strong geographical bias for molecular similarity. On further analysis of behavioural and demographic associations, binary logistic regression analysis showed that older age and non-Caucasian ethnicity were significantly associated with clustering. HCV probably evolves in micro-epidemics within geographically isolated communities.
| INTRODUCTION
Hepatitis C virus (HCV) remains one of the most prevalent and incident blood borne viral infections globally, particularly among people who inject drugs (PWID). [1] [2] [3] [4] In the United States, incident cases of HCV are increasing since 2010 and approximately 7.8%-26.7% of PWIDs are estimated to be infected annually. [5] [6] [7] [8] [9] [10] [11] The "International
Collaborative of Incident HIV and HCV in Injecting Cohorts" (InC3) has successfully created the first and largest merged international multicohort project of pooled biological and behavioural data from nine prospective observational studies (in Australia, Canada, the United States and the Netherlands) of incident HIV and HCV infections in high-risk cohorts, principally people who inject drugs (PWID). 12 This has allowed in-depth, cross-continental epidemiological analysis of incident HCV infections.
Viral sequence data have been increasingly used to complement traditional epidemiological studies examining the incidence and risk factors for infections. This molecular epidemiology approach has largely superseded the more limited analysis of simple viral traits such as genotype or viral load. 13 RNA viruses, such as HIV and HCV, feature rapid mutations across the genome, both within infected hosts and across infected populations. This rapid viral evolution allows tracking of related infections by identification of viral genomic similarities in different hosts (phylogenetics).
However, traditional phylogenetic studies on HCV have several limitations. Firstly, the molecular footprint identified from an individual host at a later time point in infection can be different from that of an early time point as the characteristics of the transmitted/founder sequence can change due to viral adaptation and host immune selection pressures. 13 Accordingly, viral sequences obtained from late infection time points (beyond 6 months in HCV infection) may be less accurate in representation of the transmission strain(s). 14 Secondly, all phylogenetic studies of HCV published to date have concentrated on selected segments of the genome for analysis, most commonly Core-E2 or NS5B. 15 The phylogenetic signal from these segments had never been compared to that of the full genome probably due to the technical difficulties in amplifying the full genome. 15, 16 Thirdly, first-generation (Sanger) sequencing used in many studies does not allow an in-depth appreciation of the quasi-species diversity of the virus within a host.
Finally, many molecular epidemiological studies on HCV were carried out within a limited geographical area and logistical difficulties in obtaining samples had prevented a detailed cross-continental molecular epidemiological analysis.
This study aimed to overcome these limitations using our recently developed technique 17 for amplification of full-length HCV genomes from serum samples stored during acute infection across nine prospective cohorts in four countries. Many samples were from North America (the United States and Canada) and Australia allowing a cross-continental phylogenetic analysis of sequences with regard to demographic and behavioural factors associated with phylogenetic clustering. Comparison of phylogenetic resolution when using full-length genome and segments of the same genome (the standard practice for many previous studies) was another aim of this study.
| METHODS

| Sample selection
Samples were selected from the individual cohorts of the InC 3 collaboration (North America (n=4), Australia (n=4) and Europe (n=1)) ( Table 1 ). The InC 3 collaborative is described in detail elsewhere.
12
The data set was searched for plasma samples collected within 180 days of the estimated date of infection and with a viral load of greater than 1000 IUmL −1 or a positive qualitative viral RNA result. The estimated date of infection was calculated as described previously. 18 When there were multiple eligible samples from the same subject, a preferred sample was selected based on two criteria in the following 
| Generation of full-length hepatitis C amplicons and sequencing
Near full-length HCV amplicons were generated from plasma or serum samples using the methods described by Bull et al. 17 In brief, viral RNA was extracted from 140 μL of serum or plasma using the QIAmp Viral RNA kit according to manufacturers' instructions (Qiagen, Chadstone
Centre, Vic, Australia). Reverse transcription of viral RNA was carried out using SuperScript III First-Strand Synthesis System (Life Technologies, Australia) and a pan-genotype primer (oligo dA 20 ). The cDNA from this step was subjected to a nested PCR with a combination of genotype specific and universal hepatitis C primers using KlenTaq LA enzyme (Clontech, USA). PCR products were subjected to gel electrophoresis (0.8% agarose) to guide selection of samples to be taken directly into library preparation for NGS, based on identification of an appropriate (9 Kb) sized band. All PCR products were purified with magnetic beads (Agencourt AMPure XP, Beckman Coulter, USA, Cat: A63881) according to the manufacturer's instructions and stored at −80°C. Plasma samples from one cohort (the Networks/SuperMIX study, Melbourne, Australia) had been collected in Lithium heparin, which is a PCR inhibitor. The RNA extracts from these samples were decontaminated using heparinase as described by Johnson et al. 19 If the full-length amplicon generation was apparently unsuccessful (no band on the gel), remaining RNA from the same extraction was used to attempt amplification of full genome in three separate fragments with a different protocol and primer sets. 14 This hemi-genomic amplification method was optimized for genotypes 1a and 3a, which were the most common genotypes in the sample. When both methods were unsuccessful, a fresh RNA extraction was undertaken from the remainder of the plasma with ultracentrifugation to concentrate the virus. For this step, up to 1 mL of plasma was centrifuged at 120 000 g for 90 minutes and the supernatant discarded. The pellet was resuspended in 140 μL of phosphate-buffered saline (PBS; Life Technologies, NSW, Australia) before being subjected to RNA extraction and full-length amplicon generation as described above.
All samples with a visible band at 9 Kb on agarose gel were subjected to NGS on a MiSeq sequencer (Illumina, San Diego, California, USA) using an optimized in-house library preparation (supplementary material 1). For samples without a visible band, the PCR product was diluted by 1:1000 and subjected to a quantitative PCR (qPCR) using two universal HCV primers (hep21b and hep22)
to amplify a 150-to 200-bp segment in the Core region. 17 Samples with at least 10 7 copies per ml in the qPCR were carried forward in the protocol for NGS (based on pilot experiments which revealed that approximately 50% of samples above this cut-off which did not show a band on gel were ultimately successfully sequenced).
The raw data from NGS were analysed to generate a consensus sequences for each sample using a bioinformatics pipeline implemented 
| Phylogenetic analysis
Only near full-length sequences (Core to NS5B, approximate length 8900) were considered for the phylogenetic analyses described here.
The consensus sequences were categorized according to genotype and aligned using the MUSCLE ( 
| Demographic data
The demographic, behavioural and clinical data for subjects in the nine individual cohorts have been merged into a common data set for shared use within the InC3 collaborative. These were used to explore associations with clustering. The data set used for this study was updated in February 2014. The variables used for this analysis include age, gender, continent of origin, ethnicity, past history of incarceration, incarceration at baseline (at time of recruitment to the study), level of education, sexual orientation, type of drug injected at baseline, being on opioid substitution therapy and HIV co-infection. These selections were based on study hypotheses (continent of origin) and previously demonstrated associations for clustering.
| Statistical analysis
Chi-square and independent t-tests were used initially to identify significant demographic and behavioural factors associated with clustering. Descriptive statistics were summarized into proportions and averages based on the scales of measurement. SPSS statistical software (version 15 IBM, New York, USA) was used for data analysis.
Statistical significance was set at P<.05. Binary logistic regression including all factors with P<.1 in bivariate analyses was conducted to identify independent associations of clustering.
| Ethical considerations
Ethics approval for this study was granted by the University of New South Wales, Australia (No. 14201). In addition, each of the individual cohorts had ethical approval for data and specimen collections.
| RESULTS
| Samples
Three hundred and sixty-eight samples collected between 1987 and 2012 met the inclusion criteria and were available from the individual cohorts. The majority of these (299, 81%) had a quantitative viral RNA load >1000 IU/mL (recorded at the time of sampling, prior to freezing for storage), while the remaining 69 (19%) only had a positive qualitative viral RNA test.
| Generation of HCV amplicons and sequencing
Near full-length HCV amplicons were successfully generated and se- (Table 1 ). The samples from the former cohort had predominantly been collected in the 1980s and had likely degradation of viral RNA; and the latter had stored samples in Lithium heparin requiring decontamination with heparinase, which was partially successful with three full and five partial genomes recovered from the 18 samples received. The most common genotypes in the InC 3 sample set were 1a, 3a and 2b, respectively (Table 2 ).
| Phylogenetic clusters recognized by the fulllength genomes
Of the 187 full-length sequences used in the analysis, only genotypes 1a, 2b and 3a were present in adequate numbers to construct phylogenetic trees (n=94, n=15 and n=68, respectively) and for these subtypes 14, 4 and 11 clusters or pairs were identified, respectively. Of the total data set (n=177), a total of 78 sequences (44%) were grouped in either a pair (n=34) or a cluster (n=44).
A flow chart on sample selection is shown in supplementary material 2. The phylogenetic trees and identified clusters for genotypes 1a and 3a are shown in Figure 1 and supplementary material in Figure 3 , respectively (bootstrap support is indicated at each node).
Two additional clusters identified by the software for genotype 1a
were later classified as nonclusters. In one pair, the envelope region of Opioid substitution therapy at recruitment (n-98) 27 (27.6) Each subject is name has following components (A) cohort abbreviation, (B) subject code, (C) HCV subtype. Cohort abbreviations: ACSD; Amsterdam cohort studies, AUS; Australian trial in acute hepatitis C, BBAASH; Baltimore before and after acute study in hepatitis, BASMGH/ LSH; Boston acute HCV study, HEP; HEPco study (Canada), HITS-p; hepatitis C incidence and transmission in prison study (Australia), HITS-c: hepatitis C incidence and transmission in community study (Australia), NET: SuperMIX study (Australia), UFO; UFO study (San Francisco, United States). Colour code: green-clusters with sequences exclusively from North America, blue-clusters with sequences exclusively from Australia, red-clusters with sequences from both continents
| Demographic and behavioural associations with clustering
This analysis was restricted to sequences from Australia and North America as only two sequences were available from Europe. Another three sequences were excluded due to nonavailability of demographic data, making the total sample size 172. The characteristics of these subjects are summarized in Table 2 .
Bivariate analyses for associations with clustering was performed:
(i) for the entire sample of 172 sequences, (ii) Australian and North
American sequences separately, (iii) patients from East and West coast of North America, (iv) for individual cohorts with a sample size >15
(HITS-p, HEP, UFO, BBA, ATAHC).
In the analysis of the entire data set, there were significant asso- Percentages indicate column percentages. **Characteristics with >10% missing data are not shown and none of them showed significant associations, *phylogenetic analysis completed with full genomes, n-175, 82 (45.5%) sequences were found to be in clusters, NA-Not applicable. *P values < 0.05 are in bold font not associated with clustering. Cohort-based analyses revealed a significant association for clustering and ethnicity (Caucasians were less likely than non-Caucasians to be in a cluster) in the HITS-p cohort (P=.027). Age, non-Caucasian ethnicity, continent of origin being Australia, incarceration at baseline and HIV co-infection were included in binary logistic regression analysis. The predictive capacity of the model increased from 55% (nonmodel) to 68% when these variables were included in the equation. The contribution of age (P=.015) and ethnicity (P=.019) remained significant when adjusted for other variables.
| Comparison of full genome versus segments in phylogenetics
The phylogenetic trees and clusters of full-length sequences for genotypes 1a and 3a were compared to that of regions and concatenated regions as mentioned in methods to see whether the full-length phylogenetic signal had better resolution compared to segments of the genome. Most studies on HCV phylogenetics had used segments of the genome so far due to technical difficulties in generating full-length genomes. Some full-length genomes (nine of genotype 1a and six of genotype 3a) in our data set had regions of ambiguous or absent reads (extending to up to 1000 nucleotides), due to incomplete sequence coverage. These were excluded from the analysis. The full genome trees were also re-drawn from this subset.
Except for one cluster in genotype 1a, all clusters identified by at least one of the subgenomic regions were also present in the full genome tree (supplementary material 4). The number of clusters predicted by individual segments of the genome varied and was consistently less than that predicted by the full genome tree. The Core was the most restrictive region in this regard. However, the concatenated Core-partial (p) E2 (without HVR1) plus NS5B region had an equal capacity to predict clusters compared to the full genome for genotype 1a (supplementary material 4). By contrast, for genotype 3a, this approach fell well short of the clusters identified using the full genome tree, as several clusters predicted by the NS3 and NS5A regions (plus the full genome) were not identified with the Core-pE2+NS5B tree.
The phylogenetic relationships were observed with better resolution when the segment of the genome used for analysis was longer and closer to the full genome ( Figure 3 ).
The Genbank accession numbers of sequences used in this manuscript are listed in supplementary material 5.
| DISCUSSION
This study utilized full-length HCV sequences from early infection time points and geographically dispersed sources to infer molecular relatedness by phylogenetics. Three novel features of this analysis are noteworthy: firstly, near full-length HCV sequences were generated with an optimized high-throughput protocol for NGS; secondly, the analysis was restricted to viral sequences from incident infections thereby enabling detection of early viral traits; and thirdly, the project was a multinational effort allowing analysis of a large number of sequences from nine separate prospective cohorts in four countries. The sequencing output of the project has more than doubled the number of publicly available, full-length genotype 3a sequences globally, and established a large repository of 1a and 3a full-length sequences from Australia.
In this study, the geographical origin of the sample strongly influenced clustering. Within the InC 3 sequence data set, the North American and Australian sequences sat apart from each other in clusters. This geographical bias in HCV phylogenetics has been proposed by previous studies that utilized selected segments of the genome. [21] [22] [23] [24] The findings here consolidate this observation by analysing full-length genomes to incorporate the complete phylogenetic signal.
It is plausible that the virus is evolving separately in micro-epidemics between communities that have restricted population mixing.
There are no previous cross-continent studies for comparison of , the HITS-p cohort, identified four likely transmission events of which three were associated with recent sharing and borrowing of needles. 13 Unfortunately, several of these selected subjects/samples from both NET and HITS-p studies did not meet the inclusion criteria for the current study.
After adjusting for other variables, older age and non-Caucasian ethnicity remained both significant predictors for clustering in the current data set. The mean age of participants (in both the clustering group and the remainder) was less than 30 years, but those in clusters were comparatively older-by 4.2 years on average, which contrasts with the finding in Vancouver described above. Although the multivariate analysis sought to identify independent associations with clustering, residual confounding with other variables remains plausible.
For instance, the term "non-Caucasian ethnicity" encompassed a wide variety of ethnicities, including African American, Hispanic, Asian and Indigenous Australians. Analysis of each ethnic group separately was not feasible due to the limited numbers in each category. In the analysis of the individual cohorts, the association with ethnicity was significant only in the HITS-p cohort which had a relatively large number of Indigenous Australians who are over-represented among PWID and within prisons in Australia. 27, 28 These trends are consistent with recent Australian epidemiological estimates. 29, 30 There were only eight HIV co-infections in the InC 3 data set analysed here, which limited the potential to observe any relationship of this cofactor with HCV clustering.
The availability of a large number of full-length genomes made it possible to carry out a comparison against utilizing one or more segments of the genome (as was the practice in many previous studies on HCV phylogenetics). 31 The most popular regions in this regard are the In conclusion, this is the largest molecular epidemiological and phylogenetic study of incident HCV infections conducted worldwide.
Pooling of viraemic samples, as well as demographic and behavioural data from two continents (Australia and North America), combined with the technological advantage of NGS analysis of full-length HCV genomes, has revealed that phylogenetic clustering was strongly influenced by the geographical origin of the sequences. This suggests that the HCV epidemic is probably evolving independently in microepidemics in geographically separated populations.
